A tailored course, built for your situation
Cross-Functional AI in Pharmaceutical R&D Operations for Audit Teams
Implementing AI Governance and Operational Fluency Across R&D and Compliance Functions
The situation this course is for
As AI accelerates drug discovery and clinical development, audit functions are being asked to validate systems they didn’t help design. Traditional audit approaches struggle to keep pace with iterative AI models, distributed data pipelines, and evolving regulatory expectations. Without structured, cross-functional strategies, audit teams risk becoming bottlenecks, or missing critical control points altogether.
Who this is for
Compliance officers, audit leads, and risk professionals in pharmaceutical organizations who need to understand, influence, and validate AI use in R&D without requiring data science expertise.
Who this is not for
This course is not for data scientists building AI models or executives seeking high-level AI strategy overviews. It is designed specifically for audit and compliance practitioners implementing operational controls.
What you walk away with
- Apply AI governance frameworks tailored to pharmaceutical R&D workflows
- Map audit controls to AI model development, validation, and deployment stages
- Collaborate effectively with data science, clinical operations, and regulatory teams
- Document audit trails that meet evolving regulatory expectations for AI transparency
- Deploy repeatable assessment patterns using included templates and checklists
The 12 modules (with all 144 chapters)
- Overview of AI in drug development
- Key terminology for non-technical auditors
- Regulatory landscape for AI in pharma
- Case studies: AI in preclinical research
- AI in clinical trial design and recruitment
- Post-market surveillance and AI
- Stakeholder map: R&D, compliance, and external regulators
- Audit relevance of AI use cases
- Common misconceptions about AI in R&D
- Data sources and lifecycle in AI models
- Model types used in pharma (ML, NLP, computer vision)
- Time-to-value cycles in AI projects
- Barriers to cross-functional alignment
- Shared vocabulary for audit and technical teams
- Joint governance committee structures
- Integrating audit into AI project lifecycles
- Defining roles: who does what in AI oversight
- Conflict resolution in technical audits
- Building trust with data science teams
- Audit participation in sprint reviews
- Documentation handoffs between teams
- Escalation paths for control gaps
- Feedback loops for continuous improvement
- Measuring collaboration effectiveness
- Risk domains: data, model, process, outcome
- Risk scoring for AI vs traditional systems
- High-risk AI use cases in pharma
- Bias and fairness in clinical data
- Transparency requirements for black-box models
- Data provenance and lineage tracking
- Model drift and revalidation triggers
- Third-party AI vendor risks
- Regulatory scrutiny hotspots
- Risk register design for AI projects
- Scenario planning for AI failures
- Linking risk assessment to audit scope
- Timing audits in agile development cycles
- Identifying audit entry points in AI workflows
- Scoping audits for model development phases
- Resource planning for technical audits
- Leveraging project documentation for audit readiness
- Pre-audit checklists for AI systems
- Sampling strategies for model outputs
- Engaging external experts when needed
- Audit program design for recurring AI reviews
- Integrating AI audits into annual planning
- Stakeholder communication plans
- Audit charter updates for AI oversight
- Data quality standards for AI training sets
- Data lineage tracking in distributed systems
- Audit trails for data transformations
- Version control for datasets
- Data access controls and audit logs
- Handling missing or biased data
- Patient data and privacy in AI models
- Data retention and deletion policies
- Validation of data preprocessing steps
- Metadata requirements for auditability
- Data reconciliation across systems
- Audit evidence collection from data pipelines
- Regulatory expectations for model validation
- Reviewing validation protocols and reports
- Assessing model performance metrics
- Monitoring for model drift in production
- Revalidation triggers and schedules
- Audit of model explainability techniques
- Comparing model outcomes to clinical expectations
- Reviewing bias testing results
- Third-party model validation oversight
- Documentation completeness checks
- Audit of model rollback procedures
- Performance dashboards for audit use
- Required documentation for AI systems
- Model cards and data cards review
- Version history for models and code
- Change control processes for AI updates
- Audit trail completeness assessment
- Document retention policies for AI artifacts
- Standard operating procedures for AI workflows
- Reviewing technical documentation clarity
- Linking documentation to control objectives
- Gap analysis for missing documentation
- Best practices from leading pharma organizations
- Audit checklist for documentation readiness
- FDA, EMA, and ICH guidance on AI
- Inspection scenarios involving AI systems
- Preparing AI-specific responses for regulators
- Common inspection findings in AI projects
- Mock inspection design for AI systems
- Evidence packages for regulatory submissions
- Cross-border compliance considerations
- Labeling requirements for AI-assisted decisions
- Audit’s role in inspection preparation
- Post-inspection follow-up and remediation
- Trend analysis of regulatory actions
- Maintaining inspection readiness continuously
- Ethical principles for AI in healthcare
- Audit of fairness and bias mitigation
- Transparency and patient consent considerations
- Human oversight mechanisms
- Accountability frameworks for AI decisions
- Reviewing ethical review board involvement
- Stakeholder engagement in AI design
- Audit of AI impact assessments
- Balancing innovation and risk
- Whistleblower mechanisms for AI concerns
- Public trust and reputational risk
- Audit reporting on ethical compliance
- Preventive vs detective controls in AI
- Automated controls for model monitoring
- Manual review points in AI workflows
- Segregation of duties in AI development
- Access controls for model deployment
- Change management for AI systems
- Incident response planning for AI failures
- Control testing methods for AI
- Key risk indicators for AI operations
- Control documentation standards
- Audit of control effectiveness
- Continuous control monitoring design
- Tailoring reports for technical and non-technical audiences
- Visualizing AI audit findings
- Executive summaries for leadership
- Presenting risk assessments to governance boards
- Follow-up on audit recommendations
- Benchmarking against industry peers
- Communicating with external auditors
- Regulatory reporting obligations
- Lessons learned documentation
- Improving audit communication over time
- Feedback collection from stakeholders
- Metrics for audit impact
- Emerging AI technologies in R&D
- Skills development for audit teams
- Investing in audit tooling for AI
- Knowledge sharing across audit functions
- Benchmarking audit maturity in AI
- Succession planning for technical auditors
- Innovation labs and audit collaboration
- Staying current with AI advancements
- Building external networks for insight
- Strategic planning for audit evolution
- Measuring audit function maturity
- Roadmap for continuous improvement
How this maps to your situation
- Audit teams entering AI oversight for the first time
- Compliance functions scaling support for multiple AI projects
- Organizations preparing for regulatory scrutiny of AI systems
- Professionals seeking structured frameworks to replace ad-hoc reviews
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 45, 60 hours total, self-paced, with modular design to support just-in-time learning.
How this compares to the alternatives
Unlike generic AI ethics courses or technical data science programs, this course is specifically designed for audit and compliance professionals in pharma, offering operational templates, regulatory context, and cross-functional strategies not available in broader offerings.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.